• CV, CME, and Certifications - Keeping Up with the Extras

    Stay up-to-date on your curriculum vitae (CV), upcoming CME requirements, personal records, and licensure status. As a new-in-practice pathologist, this may be a new routine you need to establish. Here are some tips on how to keep up with the extras.

  • Tips for Applying to Pathology Residency

    Members of the Digital Content Committee hosted a Reddit AMA. Here are some of the questions and answers about matching into a pathology residency and the best way to learn more about the specialty of pathology while in medical school.

  • Considering Pathology as Your Specialty

    Members of the Digital Content Committee answered questions about pathology residency applications, how to match into pathology, and the best way to learn more about the specialty of pathology.

  • Tips for Medical Students Interested in Pathology

    Members of the Digital Content Committee answered questions about matching into a pathology residency and the best way to learn more about the specialty of pathology while in medical school.

  • Overcoming Imposter Syndrome

    CAP member Dr. Nicole Riddle delves into Imposter Syndrome and the detrimental effects these negative beliefs can have on your professional and personal lives, not to mention your mental well-being.

  • CAR T-Cells Therapies: Opportunities and Challenges

    Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising approaches in anticancer therapy and an exponential number of pre-clinical and clinical studies are being carried out every year to expand its use. CAR T-cell therapy represents a cellular immunotherapy where T-cells are redirected against the tumor after engineered expression of CARs. CARs are receptor proteins that have been designed to give T-cells the new ability to target a specific antigen. The process involves taking T-cells from blood, editing the T-cells to express a CAR to recognize a specific antigen on the targeted cell (e.g., CD19 on B-cells or CD38 on plasma cells), growing those cells in the laboratory, and then administering them to the patient to bind to cancer cells and eliminate them.

  • Because Life Happens: 8 Succession Planning Best Practices for Medical Groups

    Succession planning should be based on a well-thought-out strategy to identify, recruit, and develop leaders at all levels of an organization. This article shares eight succession planning best practices, specifically catered to medical groups.

  • Pathologist-Led Screening Program Delivers Crucial Early Diagnosis to a Patient

    At risk for cervical cancer, Claudia Orozco’s cervical abnormalities were caught before they could progress at a See, Test & Treat program. The CAP Foundation's flagship program, See, Test & Treat is led by pathologists and provides free breast and cervical cancer screenings to underserved communities.

  • The Work of Retiring From Pathology, Part 3: The First 6 Months

    In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist. In this final part, Dr. Valenstein discusses what life was like the first six months after retiring.

  • The Work of Retiring From Pathology, Part 2: The Retirement Process

    In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist. In the second part, Dr. Valenstein addresses getting organized, making public declarations, economic transitions, electronic transitions, unwinding officially, saying goodbye, and planning for retired life.

  • The Work of Retiring From Pathology, Part 1: Deciding to Retire

    In this three-part series, Paul Valenstein, MD, FCAP, shares what he has learned on the other side of the microscope as a retired pathologist.

  • The Persuasive Pathologist

    Unlike surgeons who can operate on tumors and internists who can manage a cluster of chronic conditions, the pathologist's core skill is the accurate use of words to describe a disease or a problem. Our scalpel is the correct taxonomy and our prescription is the pathology report. However, our words can have meaning only if the reader or listener can understand them and more importantly—trust them.

  • Ongoing Disparities in Outcomes for Breast Cancer Patients

    The recent decline in breast cancer mortality rates around the world is attributed to an increase in patient education, advances in breast imaging and screening and breast cancer therapy innovations. Despite all the advances made, early breast cancer detection, treatment and control have not equally benefitted all patient populations. Breast cancer patients who are African American suffer from a higher mortality rate compared to their white counterparts in the United States.

  • Next Generation Anatomic Pathology: Innovative Imaging Technologies on the Horizon

    Recent advances and innovations in microscopic imaging technology are demonstrating the potential to significantly enhance the current clinical practice of diagnostic pathology.

  • MMR/MSI Testing Guideline: Adding Clarity to Identify Patients for Immune Checkpoint Inhibitor Therapy

  • Pressing The Sign Out Button: Nine Tips to Help You Bridge from Courage to Confidence

    Becoming a new attending in pathology is a transition into practice unlike that of any other specialty. These nine tips are a pathology-tailored version of personal management skills. The tips begin with how to gather objective performance data, the best advice I have on templates and creating a signing-out routine, and ending with mindset work, specifically ideas around self-awareness.

  • Less is More

    Labor crunches are not unique to pathology. Many, maybe all industries producing products and services experience them from time to time. However, savvy companies resolve their labor through innovation. Exemplary innovations that have surfaced over the last few decades include lean production, robotics and outsourcing. Maybe we can learn from them.

  • CAP Recommendations to Aid in Adoption of New eGFR Equation

    CAP has developed recommendations to aid adoption of the newly developed 2021 CKD-EPI-creatine equation for estimated glomerular filtration rate (eGFR). The new equation eliminates race-based adjustment factors that can delay recognition of chronic kidney disease (CKD), especially in Black/African American individuals.

  • Social Media for Pathologists: 10 Tips & Best Practices for Using Social Media and Growing a Digital Presence

    The CAP's Digital Content Committee lists 10 tips and best practices to help physicians engage on social media.

  • Genomic Alterations as Predictors of Immunotherapy Response

    The field of immuno-oncology (IO) continues to expand and evolve, delivering unprecedented clinical benefit to patients across a growing number of tumor types. However, IO therapies are not effective in all patients and can be associated with autoimmune side effects, which can be severe.

  1. Left Arrow
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10
  12. Right Arrow
Viewing 81-100 of 206